Giesen C, Del Águila Mejía J, Armon S, Cierco Jimenez R, Myles N, Goldman-Lévy G, et al.; WCT EVI MAP (2024). Exploratory evidence maps for the WHO Classification of Tumours 5th edition for lung and thymus tumors. Virchows Arch. 485(5):869–878. https://doi.org/10.1007/s00428-024-03886-6 PMID:39448408
Giesen C, Goldman-Levy G, Cree IA, Cierco Jimenez R, Machado A, Lokuhetty D (2024). WHO Classification of Tumours: moving towards the sixth edition. Histopathology. Epub ahead of print. https://doi.org/10.1111/his.15325 PMID:39293942
Wong CJW, Md Nasir ND, Koh VCY, Campbell F, Fox S, Lakhani SR, et al. (2024). Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast. Histopathology. 85(3):510–520. https://doi.org/10.1111/his.15279 PMID:39030792
Colling R, Indave I, Del Aguilla J, Cierco Jimenez R, Campbell F, Chechlińska M, et al. (2024). Moving forward on tumor pathology research reporting: a guide for pathologists from the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group. Mod Pathol. 37(7):100515. https://doi.org/10.1016/j.modpat.2024.100515 PMID:38763419
Elfer K, Gardecki E, Garcia V, Ly A, Hytopoulos E, Wen S, et al. (2024). Reproducible reporting of the collection and evaluation of annotations for artificial intelligence models. Mod Pathol. 37(4):100439. https://doi.org/10.1016/j.modpat.2024.100439 PMID:38286221
Laokulrath N, Gudi MA, Deb R, Ellis IO, Tan PH (2024). Invasive breast cancer reporting guidelines: ICCR, CAP, RCPath, RCPA datasets and future directions. Diagn Histopathol (Oxf). 30(2):87–99. https://doi.org/10.1016/j.mpdhp.2023.11.001
Colling R, Indave I, Del Aguila J, Jimenez RC, Campbell F, Chechlińska M, et al. (2024). A new hierarchy of research evidence for tumor pathology: a Delphi study to define levels of evidence in tumor pathology. Mod Pathol. 37(1):100357. https://doi.org/10.1016/j.modpat.2023.100357 PMID:37866639
Ly A, Garcia V, Blenman KRM, Ehinger A, Elfer K, Hanna MG, et al. (2024). Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research. Histopathology. 84(6):915–23. https://doi.org/10.1111/his.15140 PMID:38433289
Shafique A, Gonzalez R, Pantanowitz L, Tan PH, Machado A, Cree IA, et al. (2024). A preliminary investigation into search and matching for tumor discrimination in World Health Organization breast taxonomy using deep networks. Mod Pathol. 37(2):100381. https://doi.org/10.1016/j.modpat.2023.100381 PMID:37939901
Hart S, Garcia V, Dudgeon SN, Hanna MG, Li X, Blenman KRM, et al. (2023). Initial interactions with the FDA on developing a validation dataset as a medical device development tool. J Pathol. 261(4):378–84. https://doi.org/10.1002/path.6208 PMID:37794720
Tan PH (2023). Refining the classification of breast phyllodes tumours. Pathology. 55(4):437–48. https://doi.org/10.1016/j.pathol.2023.02.001 PMID:37085395
Tan BY, Fox SB, Lakhani SR, Tan PH (2023). Survey of recurrent diagnostic challenges in breast phyllodes tumours. Histopathology. 82(1):95–105. https://doi.org/10.1111/his.14730 PMID:36468287
Md Nasir ND, Koh VCY, Cree IA, Ruiz BII, Del Águila J, Armon S, et al. (2023). Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast. Histopathology. 82(5):704–12. https://doi.org/10.1111/his.14856 PMID:36579383
Helliwell TR, Judge MJ, Birdsong GG, Ellis DW, Srigley JR (2022). The International Collaboration on Cancer Reporting (ICCR): 10 years progress in the development of cancer pathology datasets. Int J Gynecol Pathol. 41(Suppl 1):S3–7. https://doi.org/10.1097/PGP.0000000000000899 PMID:36305531
Del Aguila Mejía J, Armon S, Campbell F, Colling R, Chechlinska M, Kowalewska M, et al. (2022). Understanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lung. BMJ Open. 12(10):e061240. https://doi.org/10.1136/bmjopen-2022-061240 PMID:36220326
White VA, Hyrcza MD, Lennerz JK, Thierauf J, Lokuhetty D, Cree IA, et al. (2022). Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities? Mod Pathol. 35(10):1484–93. https://doi.org/10.1038/s41379-022-01100-z PMID:35871081
Indave BI, Colling R, Campbell F, Tan PH, Cree IA (2022). Evidence-levels in pathology for informing the WHO classification of tumours. Histopathology. 81(4):420–5. https://doi.org/10.1111/his.14648 PMID:36089568
Elfer K, Dudgeon S, Garcia V, Blenman K, Hytopoulos E, Wen S, et al. (2022). Pilot study to evaluate tools to collect pathologist annotations for validating machine learning algorithms. J Med Imaging (Bellingham). 9(4):047501. https://doi.org/10.1117/1.JMI.9.4.047501 PMID:35911208
Garcia V, Elfer K, Peeters DJE, Ehinger A, Werness B, Ly A, et al. (2022). Development of training materials for pathologists to provide machine learning validation data of tumor-infiltrating lymphocytes in breast cancer. Cancers (Basel). 14(10):2467. https://doi.org/10.3390/cancers14102467 PMID:35626070
Chow ZL, Indave BI, Lokuhetty MDS, Ochiai A, Cree IA, White VA (2021). Misleading terminology in pathology: lack of definitions hampers communication. Virchows Arch. 479(2):425–30. [Erratum in: Virchows Arch. 2021; 479:439.] https://doi.org/10.1007/s00428-021-03069-7 PMID:33796909
Dudgeon SN, Wen S, Hanna MG, Gupta R, Amgad M, Sheth M, et al. (2021). A pathologist-annotated dataset for validating artificial intelligence: a project description and pilot study. J Pathol Inform. 12(1):45. https://doi.org/10.4103/jpi.jpi_83_20 PMID:34881099
Srigley JR, Judge M, Helliwell T, Birdsong GG, Ellis DW (2021). The International Collaboration on Cancer Reporting (ICCR): a decade of progress towards global pathology standardisation and data interoperability. Histopathology. 79(6):897–901. https://doi.org/10.1111/his.14431 PMID:34783048